Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Endothelial dysfunction in patients with chronic obstructive pulmonary disease and concomitant arterial hypertension and its correction by telmisartan plus amlodipine fixed combination

Laura Bolieva
European Respiratory Journal 2016 48: PA4617; DOI: 10.1183/13993003.congress-2016.PA4617
Laura Bolieva
1Pharmacology and Clinical Pharmacology, North-Ossetian State Medical Academy, Vladikavkaz, North Ossetia-AlaniaRussian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background. The concomitant prevalence of arterial hypertension (AH) and chronic obstructive pulmonary disease (COPD) is very high. Endothelial dysfunction (ED) seems to be the most common pathogenetic mechanism of both COPD and AH, so study of additional pleiotropic effects of antihypertensive drugs seems to be actual.

Aims. The study was carried out to evaluate the ability of telmisartan (T) plus amlodipin (A) fixed combination to correct ED in patients with COPD and AH.

Methods. Patients with COPD and AH (n=142) received T 40 mg/A 5 mg (T/A) for AH treatment for 12 weeks. ED markers (endothelin-1 (E-1), sP-selectin, ICAM-1, IL-1β, homocysteine (H)) blood levels were assessed by enzyme-linked immunosorbent assay at baseline and after 3 months of treatment. All data analyses were performed using Statistica for Windows, Release 10.0 StatSoft, Inc.

Results. E-1, sP-selectin, ICAM-1, IL-1β, H levels were significantly higher in patients with COPD and AH vs normal values at baseline. The decrease in the levels of all tested markers was shown after 12 weeks of treatment comparing with baseline: E-1 level decreased by 51.6%, sP-selectin by 28.4%, ICAM-1 by 34.3%, IL-1β by 50.8% and H by 58.8% (p <0.001).

Conclusions. The results of the study show that treatment of the patients with COPD and AH with T/A provides significant reduction of ED markers. This confirms the presence of pleiotropic effects of T/A and good prospects of its use for management of AH in patients with COPD.

  • Treatments
  • Comorbidities
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Endothelial dysfunction in patients with chronic obstructive pulmonary disease and concomitant arterial hypertension and its correction by telmisartan plus amlodipine fixed combination
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Endothelial dysfunction in patients with chronic obstructive pulmonary disease and concomitant arterial hypertension and its correction by telmisartan plus amlodipine fixed combination
Laura Bolieva
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4617; DOI: 10.1183/13993003.congress-2016.PA4617

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Endothelial dysfunction in patients with chronic obstructive pulmonary disease and concomitant arterial hypertension and its correction by telmisartan plus amlodipine fixed combination
Laura Bolieva
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4617; DOI: 10.1183/13993003.congress-2016.PA4617
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Long-term survivalaccording to Czech clinical phenotypes of COPD- Czech multicentre research database of severe COPD
  • Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD
  • Blood eosinophils and outcomes in COPD
Show more 1.12 Clinical Problems - COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society